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DEBATE
Ethics review of big data research: What 
should stay and what should be reformed?
Agata Ferretti1* , Marcello Ienca1, Mark Sheehan2, Alessandro Blasimme1, Edward S. Dove3, Bobbie Farsides4, 
Phoebe Friesen5, Jeff Kahn6, Walter Karlen7, Peter Kleist8, S. Matthew Liao9, Camille Nebeker10, 
Gabrielle Samuel11, Mahsa Shabani12, Minerva Rivas Velarde13 and Effy Vayena1 
Abstract 
Background: Ethics review is the process of assessing the ethics of research involving humans. The Ethics Review 
Committee (ERC) is the key oversight mechanism designated to ensure ethics review. Whether or not this governance 
mechanism is still fit for purpose in the data-driven research context remains a debated issue among research ethics 
experts.
Main text: In this article, we seek to address this issue in a twofold manner. First, we review the strengths and weak-
nesses of ERCs in ensuring ethical oversight. Second, we map these strengths and weaknesses onto specific chal-
lenges raised by big data research. We distinguish two categories of potential weakness. The first category concerns 
persistent weaknesses, i.e., those which are not specific to big data research, but may be exacerbated by it. The 
second category concerns novel weaknesses, i.e., those which are created by and inherent to big data projects. Within 
this second category, we further distinguish between purview weaknesses related to the ERC’s scope (e.g., how big 
data projects may evade ERC review) and functional weaknesses, related to the ERC’s way of operating. Based on this 
analysis, we propose reforms aimed at improving the oversight capacity of ERCs in the era of big data science.
Conclusions: We believe the oversight mechanism could benefit from these reforms because they will help to over-
come data-intensive research challenges and consequently benefit research at large.
Keywords: Big data, Research ethics, Ethics, IRBs, RECs, Ethics review, Biomedical research
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Background
The debate about the adequacy of the Ethics Review 
Committee (ERC) as the chief oversight body for big data 
studies is partly rooted in the historical evolution of the 
ERC. Particularly relevant is the ERC’s changing response 
to new methods and technologies in scientific research. 
ERCs—also known as Institutional Review Boards (IRBs) 
or Research Ethics Committees (RECs)—came to exist-
ence in the 1950s and 1960s [1]. Their original mission 
was to protect the interests of human research partici-
pants, particularly through an assessment of potential 
harms to them (e.g., physical pain or psychological dis-
tress) and benefits that might accrue from the proposed 
research. ERCs expanded in scope during the 1970s, from 
participant protection towards ensuring valuable and 
ethical human subject research (e.g., having researchers 
implement an informed consent process), as well as sup-
porting researchers in exploring their queries [2].
Fast forward fifty years, and a lot has changed. Today, 
biomedical projects leverage unconventional data 
sources (e.g., social media), partially inscrutable data 
analytics tools (e.g., machine learning), and unprec-
edented volumes of data [3–5]. Moreover, the evolution 
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of research practices and new methodologies such 
as post-hoc data mining have blurred the concept of 
‘human subject’ and elicited a shift towards the concept 
of data subject—as attested in data protection regula-
tions. [6, 7]. With data protection and privacy concerns 
being in the spotlight of big data research review, lan-
guage from data protection laws has worked its way into 
the vocabulary of research ethics. This terminological 
shift further reveals that big data, together with mod-
ern analytic methods used to interpret the data, creates 
novel dynamics between researchers and participants [8]. 
Research data repositories about individuals and aggre-
gates of individuals are considerably expanding in size. 
Researchers can remotely access and use large volumes 
of potentially sensitive data without communicating or 
actively engaging with study participants. Consequently, 
participants become more vulnerable and subjected to 
the research itself [9]. As such, the nature of risk involved 
in this new form of research changes too. In particular, 
it moves from the risk of physical or psychological harm 
towards the risk of informational harm, such as privacy 
breaches or algorithmic discrimination [10]. This is the 
case, for instance, with projects using data collected 
through web search engines, mobile and smart devices, 
entertainment websites, and social media platforms. The 
fact that health-related research is leaving hospital labs 
and spreading into online space creates novel opportu-
nities for research, but also raises novel challenges for 
ERCs. For this reason, it is important to re-examine the 
fit between new data-driven forms of research and exist-
ing oversight mechanisms [11].
The suitability of ERCs in the context of big data 
research is not merely a theoretical puzzle but also a 
practical concern resulting from recent developments in 
data science. In 2014, for example, the so-called ‘emo-
tional contagion study’ received severe criticism for 
avoiding ethical oversight by an ERC, failing to obtain 
research consent, violating privacy, inflicting emotional 
harm, discriminating against data subjects, and placing 
vulnerable participants (e.g., children and adolescents) 
at risk [12, 13]. In both public and expert opinion [14], a 
responsible ERC would have rejected this study because 
it contravened the research ethics principles of prevent-
ing harm (in this case, emotional distress) and adequately 
informing data subjects. However, the protocol adopted 
by the researchers was not required to undergo ethics 
review under US law [15] for two reasons. First, the data 
analyzed were considered non-identifiable, and research-
ers did not engage directly with subjects, exempting 
the study from ethics review. Second, the study team 
included both scientists affiliated with a public univer-
sity (Cornell) and Facebook employees. The affiliation of 
the researchers is relevant because—in the US and some 
other countries—privately funded studies are not subject 
to the same research protections and ethical regulations 
as publicly funded research [16]. An additional exam-
ple is the 2015 case in which the United Kingdom (UK) 
National Health Service (NHS) shared 1.6 million pieces 
of identifiable and sensitive data with Google DeepMind. 
This data transfer from the public to the private party 
took place legally, without the need for patient consent 
or ethics review oversight [17]. These cases demonstrate 
how researchers can pursue potentially risky big data 
studies without falling under the ERC’s purview. The lim-
itations of the regulatory framework for research over-
sight are evident, in both private and public contexts.
The gaps in the ERC’s regulatory process, together with 
the increased sophistication of research contexts—which 
now include a variety of actors such as universities, cor-
porations, funding agencies, public institutes, and citi-
zens associations—has led to an increase in the range of 
oversight bodies. For instance, besides traditional univer-
sity ethics committees and national oversight commit-
tees, funding agencies and national research initiatives 
have increasingly created internal ethics review boards 
[18, 19]. New participatory models of governance have 
emerged, largely due to an increase in subjects’ requests 
to control their own data [20]. Corporations are creating 
research ethics committees as well, modelled after the 
institutional ERC [21]. In May 2020, for example, Face-
book welcomed the first members of its Oversight Board, 
whose aim is to review the company’s decisions about 
content moderation [22]. Whether this increase in over-
sight models is motivated by the urge to fill the existing 
regulatory gaps, or whether it is just ‘ethics washing’, is 
still an open question. However, other types of special-
ized committees have already found their place alongside 
ERCs, when research involves international collaboration 
and data sharing [23]. Among others, data safety moni-
toring boards, data access committees, and responsible 
research and innovation panels serve the purpose of cov-
ering research areas left largely unregulated by current 
oversight [24].
The data-driven digital transformation challenges the 
purview and efficacy of ERCs. It also raises fundamental 
questions concerning the role and scope of ERCs as the 
oversight body for ethical and methodological sound-
ness in scientific research.1 Among these questions, this 
1 There is an unsettled discussion about whether ERCs ought to play a role 
in evaluating both scientific and ethical aspects of research, or whether these 
can even come apart—but we will not go into detail here. 25.Dawson AJ, 
Yentis SM. Contesting the science/ethics distinction in the review of clinical 
research. Journal of Medical Ethics. 2007;33(3):165–7, 26.Angell EL, Bryman 
A, Ashcroft RE, Dixon-Woods M. An analysis of decision letters by research 
ethics committees: the ethics/scientific quality boundary examined. BMJ 
Quality & Safety. 2008;17(2):131–6.
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article will explore whether ERCs are still capable of their 
intended purpose, given the range of novel (maybe not 
categorically new, but at least different in practice) issues 
that have emerged in this type of research. To answer 
this question, we explore some of the challenges that the 
ERC oversight approach faces in the context of big data 
research and review the main strengths and weaknesses 
of this oversight mechanism. Based on this analysis, we 
will outline possible solutions to address current weak-
nesses and improve ethics review in the era of big data 
science.
Main text
Strengths of the ethics review via ERC
Historically, ERCs have enabled cross disciplinary 
exchange and assessment [27]. ERC members typically 
come from different backgrounds and bring their per-
spectives to the debate; when multi-disciplinarity is 
achieved, the mixture of expertise provides the condi-
tions for a solid assessment of advantages and risks asso-
ciated with new research. Committees which include 
members from a variety of backgrounds are also suited to 
promote projects from a range of fields, and research that 
cuts across disciplines [28]. Within these committees, the 
reviewers’ expertise can be paired with a specific type of 
content to be reviewed. This one-to-one match can bring 
timely and, ideally, useful feedback [29]. In many coun-
tries (e.g., European countries, the United States (US), 
Canada, Australia), ERCs are explicitly mandated by law 
to review many forms of research involving human par-
ticipants; moreover, these laws also describe how such a 
body should be structured and the purview of its review 
[30, 31]. In principle, ERCs also aim to be representative 
of society and the research enterprise, including mem-
bers of the public and minorities, as well as researchers 
and experts [32]. And in performing a gatekeeping func-
tion to the research enterprise, ERCs play an important 
role: they recognize that both experts and lay people 
should have a say, with different views to contribute [33].
Furthermore, the ERC model strives to ensure inde-
pendent assessment. The fact that ERCs assess projects 
“from the outside” and maintain a certain degree of 
objectivity towards what they are reviewing, reduces 
the risk of overlooking research issues and decreases 
the risk for conflicts of interest. Moreover, being insti-
tutionally distinct—for example, being established by an 
organization that is distinct from the researcher or the 
research sponsor—brings added value to the research 
itself as this lessens the risk for conflict of interest. 
Conflict of interest is a serious issue in research ethics 
because it can compromise the judgment of reviewers. 
Institutionalized review committees might particularly 
suffer from political interference. This is the case, for 
example, for universities and health care systems (like 
the NHS), which tend to engage “in house” experts as 
ethics boards members. However, ERCs that can prove 
themselves independent are considered more trust-
worthy by the general public and data subjects; it is 
reassuring to know that an independent committee is 
overseeing research projects [34].
The ex-ante (or pre-emptive) ethical evaluation of 
research studies is by many considered the standard 
procedural approach of ERCs [35]. Though the litera-
ture is divided on the usefulness and added value pro-
vided by this form of review [36, 37], ex-ante review is 
commonly used as a mechanism to ensure the ethical 
validity of a study design before the research is con-
ducted [38, 39]. Early research scrutiny aims at risk-
mitigation: the ERC evaluates potential research risks 
and benefits, in order to protect participants’ physical 
and psychological well-being, dignity, and data privacy. 
This practice saves researchers’ resources and valuable 
time by preventing the pursuit of unethical or illegal 
paths [40]. Finally, the ex-ante ethical assessment gives 
researchers an opportunity to receive feedback from 
ERCs, whose competence and experience may improve 
the research quality and increase public trust in the 
research [41].
All strengths mentioned in this section are strengths of 
the ERC model in principle. In practice, there are many 
ERCs that are not appropriately interdisciplinary or rep-
resentative of the population and minorities, that lack 
independence from the research being reviewed, and that 
fail to improve research quality, and may in fact hinder 
it. We now turn to consider some of these weaknesses in 
more detail.
Weaknesses of the ethics review via ERC
In order to assess whether ERCs are adequately equipped 
to oversee big data research, we must consider the weak-
nesses of this model. We identify two categories of weak-
nesses which are described in the following section and 
summarized in Fig. 1:
– Persistent weaknesses: those existing in the current 
oversight system, which could be exacerbated by big 
data research
– Novel weaknesses: those brought about by and spe-
cific to the nature of big data projects
 Within this second category of novel weaknesses, we 
further differentiate between:
– Purview weaknesses: reasons why some big data pro-
jects may bypass the ERCs’ purview
– Functional weaknesses: reasons why some ERCs may 
be inadequate to assess big data projects specifically
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We base the conceptual distinction between persistent 
and novel weaknesses on the fact that big data research 
diverges from traditional biomedical research in many 
respects. As previously mentioned, big data projects are 
often broad in scope, involve new actors, use unprec-
edented methodologies to analyze data, and require 
specific expertise. Furthermore, the peculiarities of big 
data itself (e.g., being large in volume and from a variety 
of sources) make data-driven research different in prac-
tice from traditional research. However, we should not 
consider the category of “novel weaknesses” a closed 
category. We do not argue that weaknesses mentioned 
here do not, at least partially, overlap with others which 
already exist. In fact, in almost all cases of ‘novelty’, (i) 
there is some link back to a concept from traditional 
research ethics, and (ii) some thought has been given 
to the issue outside of a big data or biomedical context 
(e.g., the problem of ERCs’ expertise has arisen in other 
fields [42]). We believe that by creating conceptual clar-
ity about novel oversight challenges presented by big data 
research, we can begin to identify tailored reforms.
Persistent weaknesses
As regulation for research oversight varies between 
countries, ERCs often suffer from a lack of harmoniza-
tion. This weakness in the current oversight mechanism 
is compounded by big data research, which often relies 
on multi-center international consortia. These consortia 
in turn depend on approval by multiple oversight bodies 
demanding different types of scrutiny [43]. Furthermore, 
big data research may give rise to collaborations between 
public bodies, universities, corporations, foundations, 
and citizen science cooperatives. In this network, each 
stakeholder has different priorities and depends upon its 
own rules for regulation of the research process [44–46]. 
Indeed, this expansion of regulatory bodies and aims 
does not come with a coordinated effort towards agreed-
upon review protocols [47]. The lack of harmonization 
is perpetuated by academic journals and funding bod-
ies with diverging views on the ethics of big data. If the 
review bodies which constitute the “ethics ecosystem” 
[19] do not agree to the same ethics review require-
ments, a big data project deemed acceptable by an ERC 
in one country may be rejected by another ERC, within 
or beyond the national borders.
In addition, there is inconsistency in the assessment 
criteria used within and across committees. Researchers 
report subjective bias in the evaluation methodology of 
ERCs, as well as variations in ERC judgements which are 
not based on morally relevant contextual considerations 
[48, 49]. Some authors have argued that the probability 
of research acceptance among experts increases if some 
research peer or same-field expert sits on the evaluation 
committee [50, 51]. The judgement of an ERC can also be 
influenced by the boundaries of the scientific knowledge 
of its members. These boundaries can impact the ERC’s 
approach towards risk taking in unexplored fields of 
research [52]. Big data research might worsen this prob-
lem since the field is relatively new, with no standardized 
metric to assess risk within and across countries [53]. The 





Inconsistent review criteria  within 
and across ERCs
Unsuitability to redistribute the risks 
and benefits of research
Conflicting regulation across 
jurisdictions
Overwhelming no. of projects to 
review
New actors conducting research
Use of anonymised data
Broad scope of big data studies
Informed consent operationalisation 
Unforeseeable risks assessment
Ex-ante review model
Lack of expertise in big data
Fig. 1 Weaknesses of the ERCs
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committees do not necessarily communicate with each 
other to clarify their specific role in the review process, 
or try to streamline their approach to the assessment. 
This results in unclear oversight mandates and inconsist-
ent ethical evaluations [27, 54].
Additionally, ERCs may fall short in their efforts to 
justly redistribute the risks and benefits of research. The 
current review system is still primarily tilted toward pro-
tecting the interests of individual research participants. 
ERCs do not consistently assess societal benefit, or risks 
and benefits in light of the overall conduct of research 
(balancing risks for the individual with collective ben-
efits). Although demands on ERCs vary from country to 
country [55], the ERC approach is still generally tailored 
towards traditional forms of biomedical research, such as 
clinical trials and longitudinal cohort studies with hos-
pital patients. These studies are usually narrow in scope 
and carry specific risks only for the participants involved. 
In contrast, big data projects can impact society more 
broadly. As an example, computational technologies have 
shown potential to determine individuals’ sexual ori-
entation by screening facial images [56]. An inadequate 
assessment of the common good resulting from this type 
of study can be socially detrimental [57]. In this sense, 
big data projects resemble public health research stud-
ies, with an ethical focus on the common good over indi-
vidual autonomy [58]. Within this context, ERCs have 
an even greater responsibility to ensure the just distri-
bution of research benefits across the population. Accu-
rately determining the social value of big data research 
is challenging, as negative consequences may be difficult 
to detect before research begins. Nevertheless, this task 
remains a crucial objective of research oversight.
The literature reports examples of the failure of ERCs 
to be accountable and transparent [59]. This might be 
the result of an already unclear role of ERCs. Indeed, 
the ERCs practices are an outcome of different levels of 
legal, ethical, and professional regulations, which largely 
vary across jurisdictions. Therefore, some ERCs might 
function as peer counselors, others as independent advi-
sors, and still others as legal controllers. What seems to 
be common across countries, though, is that ERCs rarely 
disclose their procedures, policies, and decision-making 
process. The ERCs’ “secrecy” can result in an absence of 
trust in the ethical oversight model [60].This is problem-
atic because ERCs rely on public acceptance as account-
able and trustworthy entities [61]. In big data research, 
as the number of data subjects is exponentially greater, 
a lack of accountability and an opaque deliberative pro-
cess on the part of ERCs might bring even more signifi-
cant public backlash. Ensuring truthfulness of the stated 
benefits and risks of research is a major determinant of 
trust in both science and research oversight. Researchers 
are another category of stakeholders negatively impacted 
by poor communication and publicity on the part of the 
ERC. Commentators have shown that ERCs often do 
not clearly provide guidance about the ethical stand-
ards applied in the research review [62]. For instance, if 
researchers provide unrealistic expectations of privacy 
and security to data subjects, ERCs have an institutional 
responsibility to flag those promises (e.g., about data 
security and the secondary-uses of subject data), espe-
cially when the research involves personal and high sen-
sitivity data [63]. For their part, however, ERCs should 
make their expectations and decision-making processes 
clear.
Finally, ERCs face the increasing issue of being over-
whelmed by the number of studies to review [64, 65]. 
Whereas ERCs originally reviewed only human subjects 
research happening in natural sciences and medicine, 
over time they also became the ethical body of refer-
ence for those conducting human research in the social 
sciences (e.g., in behavioral psychology, educational sci-
ences, etc.). This increase in demand creates pressure on 
ERC members, who often review research pro bono and 
on a voluntary basis. The wide range of big data research 
could exacerbate this existing issue. Having more 
research to assess and less time to accomplish the task 
may negatively impact the quality of the ERC’s output, 
as well as increase the time needed for review [66]. Con-
sequently, researchers might carry out potentially risky 
studies because the relevant ethical issues of those stud-
ies were overlooked. Furthermore, research itself could 
be significantly delayed, until it loses its timely scientific 
value.
Novel weaknesses: purview weaknesses
To determine whether the ERC is still the most fit-for-
purpose entity to oversee big data research, it is impor-
tant to establish under which conditions big data projects 
fall under the purview of ERCs.
Historically, research oversight has primarily focused 
on human subject research in the biomedical field, using 
public funding. In the US for instance, each review board 
is responsible for a subtype of research based on content 
or methodology (for example there are IRBs dedicated 
to validating clinical trial protocols, assessing cancer 
treatments, examining pediatric research, and review-
ing qualitative research). This traditional ethics review 
structure cannot accommodate big data research [2]. 
Big data projects often reach beyond a single institu-
tion, cut across disciplines, involve data collected from 
a variety of sources, re-use data not originally collected 
for research purposes, combine diverse methodologies, 
orient towards population-level research, rely on large 
data aggregates, and emerge from collaboration with the 
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private sector. Given this scenario, big data projects may 
likely fall beyond the purview of ERCs.
Another case in which big data research does not fall 
under ERC purview is when it relies on anonymized 
data. If researchers use data that cannot be traced back 
to subjects (anonymized or non-personal data), then 
according to both the US Common Rule and HIPAA 
regulations, the project is considered safe enough to be 
granted an ethics review waiver. If instead researchers 
use pseudonymized (or de-identified) data, they must 
apply for research ethics review, as in principle the key 
that links the de-identified data with subjects could be 
revealed or hacked, causing harm to subjects. In the 
European Union, it would be left to each Member State 
(and national laws or policies at local institutions) to 
define whether research using anonymized data should 
seek ethical review. This case shows once more that cur-
rent research ethics regulation is relatively loose and dis-
jointed across jurisdictions, and may leave areas where 
big data research is unregulated. In particular, the special 
treatment given anonymized data comes from an empha-
sis on risk at the individual level. So far in the big data 
discourse, the concept of harm has been mainly linked 
to vulnerability in data protection. Therefore if privacy 
laws are respected, and protection is built into the data 
system, researchers can prevent harmful outcomes [40]. 
However, this view is myopic as it does not include other 
misuses of data aggregates, such as group discrimina-
tion and dignitary harm. These types of harm are already 
emerging in the big data ecosystem, where anonymized 
data reveal health patterns of a certain sub-group, or 
computational technologies include strong racial biases 
[67, 68]. Furthermore, studies using anonymized data 
should not be deemed oversight-free by default, as it is 
increasingly hard to anonymize data. Technological 
advancements might soon make it possible to re-identify 
individuals from aggregate data sets [69].
The risks associated with big data projects also increase 
due to the variety of actors involved in research along-
side university researchers (e.g., private companies, citi-
zen science associations, bio-citizen groups, community 
workers cooperatives, foundations, and non-profit organ-
izations) [70, 71]. The novel aspect of health-related big 
data research compared with traditional research is that 
anyone who can access large amounts of data about indi-
viduals and build predictive models based on that data, 
can now determine and infer the health status of a person 
without directly engaging with that person in a research 
program [72]. Facebook, for example, is carrying out a 
suicide prediction and prevention project, which relies 
exclusively on the information that users post on the 
social network [18]. Because this type of research is now 
possible, and the available ethics review model exempts 
many big data projects from ERC appraisal, gaps in 
oversight are growing [17, 73]. Just as corporations can 
re-use publicly available datasets (such as social media 
data) to determine life insurance premiums [74], citi-
zen science projects can be conducted without seeking 
research oversight [75]. Indeed, participant-led big data 
research (despite being increasingly common) is another 
area where the traditional overview model is not effec-
tive [76]. In addition, ERCs might consider research 
conducted outside academia or publicly funded institu-
tions to be not serious. Thus ERCs may disregard review 
requests from actors outside the academic environment 
(e.g., by the citizen science or health tech start up) [77].
Novel weaknesses: functional weaknesses
Functional weaknesses are those related to the skills, 
composition, and operational activities of ERCs in rela-
tion to big data research.
From this functional perspective, we argue that the ex-
ante review model might not be appropriate for big data 
research. Project assessment at the project design phase 
or at the data collection level is insufficient to address 
emerging challenges that characterize big data projects 
– especially as data, over time, could become useful for 
other purposes, and therefore be re-used or shared [53]. 
Limitations of the ex-ante review model have already 
become apparent in the field of genetic research [78]. In 
this context, biobanks must often undergo a second eth-
ics assessment to authorize the specific research use on 
exome sequencing of their primary data samples [79]. 
Similarly, in a case in which an ERC approved the origi-
nal collection of sensitive personal data, a data access 
committee would ensure that the secondary uses are in 
line with original consent and ethics approval.  How-
ever, if researchers collect data from publicly accessible 
platforms, they can potentially use and re-use data for 
research lawfully, without seeking data subject consent 
or ERC review. This is often the case in social media 
research. Social media data, which are collected by 
researchers or private companies using a form of broad 
consent, can be re-used by researchers to conduct addi-
tional analysis without ERC approval. It is not only the 
re-use of data that poses unforeseeable risks. The ex-ante 
approach might not be suitable to assess other stages 
of the data lifecycle [80], such as deployment machine 
learning algorithms.
Rather than re-using data, some big data studies build 
models on existing data (using data mining and machine 
learning methods), creating new data, which is then used 
to further feed the algorithms [81]. Sometimes it is not 
possible to anticipate which analytic models or tools (e.g., 
artificial intelligence) will be leveraged in the research. 
And even then, the nature of computational technologies 
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which extract meaning from big data make it difficult to 
anticipate all the correlations that will emerge from the 
analysis [37]. This is an additional reason that big data 
research often has a tentative approach to a research 
question, instead of growing from a specific research 
hypothesis [82].The difficulty of clearly framing the big 
data research itself makes it even harder for ERCs to 
anticipate unforeseeable risks and potential societal con-
sequences. Given the existing regulations and the intrin-
sic exploratory nature of big data projects, the mandate of 
ERCs does not appear well placed to guarantee research 
oversight. It seems even less so if we consider problems 
that might arise after the publication of big data studies, 
such as repurposing or dual-use issues [83].
ERCs also face the challenge of assessing the value of 
informed consent for big data projects. To re-obtain con-
sent from research subjects is impractical, particularly 
when using consumer generated data (e.g., social media 
data) for research purposes. In these cases, research-
ers often rely on broad consent and consent waivers. 
This leaves the data subjects unaware of their participa-
tion in specific studies, and therefore makes them inca-
pable of engaging with the research progress. Therefore, 
the data subjects and the communities they represent 
become vulnerable towards potential negative research 
outcomes. The tool of consent has limitations in big data 
research—it cannot disclose all possible future uses of 
data, in part because these uses may be unknown at the 
time of data generation. Moreover, researchers can access 
existing datasets multiple times and reuse the same data 
with alternative purposes [84]. What should be the ERCs’ 
strategy, given the current model of informed consent 
leaves an ethical gap in big data projects? ERCs may be 
tempted to focus on the consent challenge, neglecting 
other pressing big data issues [53]. However, the litera-
ture reports an increasing number of authors who are 
against the idea of a new consent form for big data stud-
ies [5].
A final widely discussed concern is the ERC’s inad-
equate expertise in the area of big data research [85, 86]. 
In the past, there have been questions about the technical 
and statistical expertise of ERC members. For example, 
ERCs have attempted to conform social science research 
to the clinical trial model, using the same knowledge and 
approach to review both types of research [87]. How-
ever, big data research poses further challenges to ERCs’ 
expertise. First, the distinct methodology of big data 
studies (based on data aggregation and mining) requires a 
specialized technical expertise (e.g., information systems, 
self-learning algorithms, and anonymization protocols). 
Indeed, big data projects have a strong technical compo-
nent, due to data volume and sources, which brings spe-
cific challenges (e.g., collecting data outside traditional 
protocols on social media) [88, 89]. Second, ERCs may 
be unfamiliar with new actors involved in big data 
research, such as citizen science actors or private corpo-
rations. Because of this lack of relevant expertise, ERCs 
may require unjustified amendments to research studies, 
or even reject big data projects tout-court [36]. Finally, 
ERCs may lose credibility as an oversight body capable of 
assessing ethical violations and research misconduct. In 
the past, ERCs solved this challenge by consulting inde-
pendent experts in a relevant field when reviewing a pro-
tocol in that domain. However, this solution is not always 
practical as it depends upon the availability of an expert. 
Furthermore, experts may be researchers working and 
publishing in the field themselves. This scenario would 
be problematic because researchers would have to define 
the rules experts must abide by, compromising the con-
cept of independent review [19]. Nonetheless, this prob-
lem does not disqualify the idea of expertise but requires 
high transparency standards regarding rule development 
and compliance. Other options include ad-hoc expert 
committees or provision of relevant training for existing 
committee members [47, 90, 91]. Given these options, 
which one is best to address ERCs’ lack of expertise in big 
data research?
Reforming the ERC
Our analysis shows that ERCs play a critical role in 
ensuring ethical oversight and risk–benefit evaluation 
[92], assessing the scientific validity of a project in its 
early stages, and offering an independent, critical, and 
interdisciplinary approach to the review. These strengths 
demonstrate why the ERC is an oversight model worth 
holding on to. Nevertheless, ERCs carry persistent big 
data-specific weaknesses, reducing their effectiveness 
and appropriateness as oversight bodies for data-driven 
research. To answer our initial research question, we pro-
pose that the current oversight mechanism is not as fit 
for purpose to assess the ethics of big data research as it 
could be in principle. ERCs should be improved at sev-
eral levels to be able to adequately address and overcome 
these challenges. Changes could be introduced at the 
level of the regulatory framework as well as procedures. 
Additionally, reforming the ERC model might mean 
introducing complementary forms of oversight. In this 
section we explore these possibilities. Figure 2 offers an 
overview of the reforms that could aid ERCs in improving 
their process.
Regulatory reforms
The regulatory design of research oversight is the first 
aspect which needs reform. ERCs could benefit from new 
guidance (e.g., in the form of a flowchart) on the ethics of 
big data research. This guidance could build upon a deep 
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rethinking of the importance of data for the functioning 
of societies, the way we use data in society, and our justi-
fications for this use. In the UK, for instance, individuals 
can generally opt out of having their data (e.g., hospital 
visit data, health records, prescription drugs) stored by 
physicians’ offices or by NHS digital services. However, 
exceptions to this opt-out policy apply when uses of the 
data are vital to the functioning of society (for example, 
in the case of official national statistics or overriding pub-
lic interest, such as the COVID-19 pandemic) [93].
We imagine this new guidance also re-defining the 
scope of ERC review, from protection of individual inter-
est to a broader research impact assessment. In other 
words, it will allow the ERC’s scope to expand and to 
address purview issues which were previously discussed. 
For example, less research will be oversight-free because 
more factors would trigger ERC purview in the first 
place. The new governance would impose ERC review for 
research involving anonymized data, or big data research 
within public–private partnerships. Furthermore, ERC 
purview could be extended beyond the initial phase of 
the study to other points in the data lifecycle [94]. A pos-
sible option is to assess a study after its conclusion (as 
is the case in the pharmaceutical industry): ERCs could 
then decide if research findings and results should be 
released and further used by the scientific community. 
This new ethical guidance would serve ERCs not only 
in deciding whether a project requires review, but also 
in learning from past examples and best practices how 
to best proceed in the assessment. Hence, this guidance 
could come in handy to increase transparency surround-
ing assessment criteria used across ERCs. Transparency 
could be achieved by defining a minimum global standard 
for ethics assessment that allows international collabora-
tion based on open data and a homogenous evaluation 
model. Acceptance of a global standard would also mean 
that the same oversight procedures will apply to research 
projects with similar risks and research paths, regardless 
of whether they are carried on by public or private enti-
ties. Increased clarification and transparency might also 
streamline the review process within and across commit-
tees, rendering the entire system more efficient.
Procedural reforms
Procedural reforms might target specific aspects of the 
ERC model to make it more suitable for the review of big 
data research. To begin with, ERCs should develop new 
operational tools to mitigate emerging big data chal-
lenges. For example, the AI Now algorithmic impact 
assessment tool, which appraises the ethics of automated 
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decision systems, and informs decisions about whether 
or not to deploy the systems in society, could be used 
[95]. Forms of broad consent [96] and dynamic consent 
[20] can also address some of the issues raised, by using, 
re-using, and sharing big data (publicly available or not). 
Nonetheless, informed consent should not be considered 
a panacea for all ethical issues in big data research—espe-
cially in the case of publicly available social media data 
[97]. If the ethical implications of big data studies affect 
the society and its vulnerable sub-groups, individual 
consent cannot be relied upon as an effective safeguard. 
For this reason, ERCs should move towards a more 
democratic process of review. Possible strategies include 
engaging research subjects and communities in the deci-
sion-making process or promoting a co-governance sys-
tem. The recent Montreal Declaration for Responsible AI 
is an example of an ethical oversight process developed 
out of public involvement [98]. Furthermore, this inclu-
sive approach could increase the trustworthiness of the 
ethics review mechanism itself [99]. In practice, the more 
that ERCs involve potential data subjects in a transpar-
ent conversation about the risks of big data research, the 
more socially accountable the oversight mechanism will 
become.
ERCs must also address their lack of big data and gen-
eral computing expertise. There are several potential 
ways to bridge this gap. First, ERCs could build capacity 
with formal training on big data. ERCs are willing to learn 
from researchers about social media data and computa-
tional methodologies used for data mining and analysis 
[85]. Second, ERCs could adjust membership to include 
specific experts from needed fields (e.g., computer scien-
tists, biotechnologists, bioinformaticians, data protection 
experts). Third, ERCs could engage with external experts 
for specific consultations. Despite some resistance to 
accepting help, recent empirical research has shown that 
ERCs may be inclined to rely upon external experts in 
case of need [86].
In the data-driven research context, ERCs must 
embrace their role as regulatory stewards, and walk 
researchers through the process of ethics review [40]. 
ERCs should establish an open communication channel 
with researchers to communicate the value of research 
ethics while clarifying the criteria used to assess research. 
If ERCs and researchers agree to mutually increase 
transparency, they create an opportunity to learn from 
past mistakes and prevent future ones [100]. Universi-
ties might seek to educate researchers on ethical issues 
that can arise when conducting data-driven research. 
In general, researchers would benefit from training on 
identifying issues of ethics or completing ethics self-
assessment forms, particularly if they are responsible 
for submitting projects for review [101]. As biomedical 
research is trending away from hospitals and clinical 
trials, and towards people’s homes and private corpora-
tions, researchers should strive towards greater clarity, 
transparency, and responsibility. Researchers should dis-
close both envisioned risks and benefits, as well as the 
anticipated impact at the individual and population level 
[54]. ERCs can then more effectively assess the impact of 
big data research and determine whether the common 
good is guaranteed. Furthermore, they might examine 
how research benefits are distributed throughout soci-
ety. Localized decision making can play a role here [55]. 
ERCs may take into account characteristics specific to the 
social context, to evaluate whether or not the research 
respects societal values.
Complementary reforms
An additional measure to tackle the novelty of big data 
research might consist in reforming the current research 
ethics system through regulatory and procedural tools. 
However, this strategy may not be sufficient: the cur-
rent system might require additional support from other 
forms of oversight to complement its work.
One possibility is the creation of hybrid review mecha-
nisms and norms, merging valuable aspects of the tradi-
tional ERC review model with more innovative models, 
which have been adopted by various partners involved 
in the research (e.g., corporations, participants, com-
munities) [102]. This integrated mechanism of oversight 
would cover all stages of big data research and involve all 
relevant stakeholders [103]. Journals and the publishing 
industry could play a role within this hybrid ecosystem in 
limiting potential dual use concerns. For instance, in the 
research publication phase, resources could be assigned 
to editors so as to assess research integrity standards and 
promote only those projects which are ethically aligned. 
However, these implementations can have an impact only 
when there is a shared understanding of best practice 
within the oversight ecosystem [19].
A further option is to include specialized and distinct 
ethical committees alongside ERCs, whose purpose is to 
assess big data research and provide sectorial accredi-
tation to researchers. In this model, ERCs would not 
be overwhelmed by the numbers of study proposals to 
review and could outsource evaluations requiring spe-
cialist knowledge in the field of big data. It is true that 
specialized committees (data safety monitoring boards, 
data access committees, and responsible research and 
innovation panels) already exist and support big data 
researchers in ensuring data protection (e.g., system 
security, data storage, data transfer). However, something 
like a “data review board” could assess research implica-
tions both for the individual and society, while review-
ing a project’s technical features. Peer review could play 
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a critical role in this model: the research community 
retains the expertise needed to conduct ethical research 
and to support each other when the path is unclear [101].
Despite their promise, these scenarios all suffer from 
at least one primary limitation. The former might face a 
backlash when attempting to bring together the priorities 
and ethical values of various stakeholders, within com-
mon research norms. Furthermore, while decentralized 
oversight approaches might bring creativity over how to 
tackle hard problems, they may also be very dispersive 
and inefficient. The latter could suffer from overlapping 
scope across committees, resulting in confusing proce-
dures, and multiplying efforts while diluting liability. For 
example, research oversight committees have multiplied 
within the United States, leading to redundancy and dis-
harmony across committees [47]. Moreover, specialized 
big data ethics committees working in parallel with cur-
rent ERCs could lead to questions over the role of the tra-
ditional ERC, when an increasing number of studies will 
be big data studies.
Conclusions
ERCs face several challenges in the context of big data 
research. In this article, we sought to bring clarity regard-
ing those which might affect the ERC’s practice, distin-
guishing between novel and persistent weaknesses which 
are compounded by big data research. While these flaws 
are profound and inherent in the current sociotechnical 
transformation, we argue that the current oversight model 
is still partially capable of guaranteeing the ethical assess-
ment of research. However, we also advance the notion 
that introducing reform at several levels of the oversight 
mechanism could benefit and improve the ERC system 
itself. Among these reforms, we identify the urgency for 
new ethical guidelines and new ethical assessment tools 
to safeguard society from novel risks brought by big data 
research. Moreover, we recommend that ERCs adapt their 
membership to include necessary expertise for addressing 
the research needs of the future. Additionally, ERCs should 
accept external experts’ consultations and consider training 
in big data technical features as well as big data ethics. A 
further reform concerns the need for transparent engage-
ment among stakeholders. Therefore, we recommend that 
ERCs involve both researchers and data subjects in the 
assessment of big data research. Finally, we acknowledge 
the existing space for a coordinated and complementary 
support action from other forms of oversight. However, 
the actors involved must share a common understanding 
of best practice and assessment criteria in order to effi-
ciently complement the existing oversight mechanism. We 
believe that these adaptive suggestions could render the 
ERC mechanism sufficiently agile and well-equipped to 
overcome data-intensive research challenges and benefit 
research at large.
Abbreviations
ERC(s): Ethics Review Committee(s); HIPAA: Health Insurance Portability and 
Accountability Act; IRB(s): Institutional Review Board(s); NHS: National Health 
Service; REC(s): Research Ethics Committee(s); UK: United Kingdom; US: United 
States.
Acknowledgements
This article reports the ideas and the conclusions emerged during a col-
laborative and participatory online workshop. All authors participated in the 
“Big Data Challenges for Ethics Review Committees” workshop, held online 
the 23-24 April 2020 and organized by the Health Ethics and Policy Lab, ETH 
Zurich.
Authors’ contributions
AF drafted the manuscript, MI, MS1 and EV contributed substantially to the 
writing. EV is the senior lead on the project from which this article derives. All 
the authors (AF, MI, MS1, AB, ESD, BF, PF, JK, WK, PK, SML, CN, GS, MS2, MRV, 
EV) contributed greatly to the intellectual content of this article, edited it, and 
approved the final version. All authors read and approved the final manuscript.
Funding
This research is supported by the Swiss National Science Foundation under 
award 407540_167223 (NRP 75 Big Data). MS1 is grateful for funding from 
the National Institute for Health Research (NIHR) Oxford Biomedical Research 
Centre (BRC). The funding bodies did not take part in designing this research 
and writing the manuscript.
Availability of data and materials
Not applicable.
Declarations





The authors declare that they have no competing interests.
Author details
1 Health Ethics and Policy Lab, Department of Health Sciences and Technology, 
ETH Zürich, Hottingerstrasse 10 (HOA), 8092 Zürich, Switzerland. 2 The Ethox 
Centre, Department of Population Health, University of Oxford, Oxford, UK. 
3 School of Law, University of Edinburgh, Edinburgh, UK. 4 Brighton and Sus-
sex Medical School, Brighton, UK. 5 Biomedical Ethics Unit, Department 
of Social Studies of Medicine, McGill University, Montreal, Canada. 6 Johns 
Hopkins Berman Institute of Bioethics, Baltimore, USA. 7 Mobile Health Systems 
Lab, Department of Health Sciences and Technology, ETH Zürich, Zürich, 
Switzerland. 8 Cantonal Ethics Committee Zürich, Zürich, Switzerland. 9 Center 
for Bioethics, Department of Philosophy, New York University, New York, 
USA. 10 Research Center for Optimal Digital Ethics in Health (ReCODE Health), 
Herbert Wertheim School of Public Health and Longevity Science, University 
of California, San Diego, USA. 11 Department of Global Health and Social Medi-
cine, King’s College London, London, UK. 12 Faculty of Law and Criminology, 
Ghent University, Ghent, Belgium. 13 Department of Radiology and Medical 
Informatics, Faculty of Medicine, University of Geneva, Geneva, Switzerland. 
Received: 23 November 2020   Accepted: 15 April 2021
Page 11 of 13Ferretti et al. BMC Med Ethics           (2021) 22:51  
References
 1. Moon MR. The history and role of institutional review boards: A useful 
tension. AMA J Ethics. 2009;11(4):311–6.
 2. Friesen P, Kearns L, Redman B, Caplan AL. Rethinking the Belmont 
report? Am J Bioeth. 2017;17(7):15–21.
 3. Nebeker C, Torous J, Ellis RJB. Building the case for actionable ethics in 
digital health research supported by artificial intelligence. BMC Med. 
2019;17(1):137.
 4. Ienca M, Ferretti A, Hurst S, Puhan M, Lovis C, Vayena E. Considerations 
for ethics review of big data health research: A scoping review. PloS 
one. 2018;13(10).
 5. Hibbin RA, Samuel G, Derrick GE. From “a fair game” to “a form of covert 
research”: Research ethics committee members’ differing notions of 
consent and potential risk to participants within social media research. 
J Empir Res Hum Res Ethics. 2018;13(2):149–59.
 6. Maldoff G. How GDPR changes the rules for research: International 
Association of Privacy Protection; 2020 [Available from: https:// iapp. org/ 
news/a/ how- gdpr- chang es- the- rules- for- resea rch/.
 7. Samuel G, Buchanan E. Guest Editorial: Ethical Issues in Social Media 
Research. SAGE Publications Sage CA: Los Angeles, CA; 2020. p. 3–11.
 8. Shmueli G. Research Dilemmas with Behavioral Big Data. Big Data. 
2017;5(2).
 9. Sula CA. Research ethics in an age of big data. Bull Assoc Inf Sci Technol. 
2016;42(2):17–21.
 10. Metcalf J, Crawford K. Where are human subjects in Big Data research? 
The emerging ethics divide. Big Data Soc. 2016;3(1):2053951716650211.
 11. Vayena E, Gasser U, Wood AB, O’Brien D, Altman M. Elements of a new 
ethical framework for big data research. Washington and Lee Law 
Review Online. 2016;72(3).
 12. Goel V. As Data Overflows Online, Researchers Grapple With Ethics: The 
New York Times; 2014 [Available from: https:// www. nytim es. com/ 2014/ 
08/ 13/ techn ology/ the- boon- of- online- data- puts- social- scien ce- in-a- 
quand ary. html.
 13. Vitak J, Shilton K, Ashktorab Z, editors. Beyond the Belmont principles: 
Ethical challenges, practices, and beliefs in the online data research 
community. Proceedings of the 19th ACM Conference on Computer-
Supported Cooperative Work & Social Computing; 2016.
 14. BBC World. Facebook emotion experiment sparks criticism 2014 [Avail-
able from: https:// www. bbc. com/ news/ techn ology- 28051 930.
 15. Fiske ST, Hauser RM. Protecting human research participants in the age 
of big data. Proc Natl Acad Sci USA. 2014;111(38):13675.
 16. Klitzman R, Appelbaum PS. Facebook’s emotion experiment: Implica-
tions for research ethics: The Hastings Center; 2014 [Available from: 
https:// www. theha sting scent er. org/ faceb ooks- emoti on- exper iment- 
impli catio ns- for- resea rch- ethics/.
 17. Ballantyne A, Stewart C. Big Data and Public-Private Partnerships in 
Healthcare and Research. Asian Bioethics Review. 2019;11(3):315–26.
 18. Barnett I, Torous J. Ethics, transparency, and public health at the 
intersection of innovation and Facebook’s suicide prevention efforts. 
American College of Physicians; 2019.
 19. Samuel G, Derrick GE, van Leeuwen T. The ethics ecosystem: Personal 
ethics, network governance and regulating actors governing the use of 
social media research data. Minerva. 2019;57(3):317–43.
 20. Vayena E, Blasimme A. Biomedical big data: new models of con-
trol over access, use and governance. Journal of bioethical inquiry. 
2017;14(4):501–13.
 21. BBC World. Google announces AI ethics panel: BBC World; 2019 [Avail-
able from: https:// www. bbc. com/ news/ techn ology- 47714 921.
 22. Clegg N. Welcoming the Oversight Board - About Facebook: FACE-
BOOK; 2020 [updated 2020–05–06. Available from: https:// about. fb. 
com/ news/ 2020/ 05/ welco ming- the- overs ight- board/.
 23. Shabani M, Dove ES, Murtagh M, Knoppers BM, Borry P. Oversight of 
genomic data sharing: what roles for ethics and data access commit-
tees? Biopreservation and biobanking. 2017;15(5):469–74.
 24. Joly Y, Dove ES, Knoppers BM, Bobrow M, Chalmers D. Data sharing in 
the post-genomic world: the experience of the International Cancer 
Genome Consortium (ICGC) Data Access Compliance Office (DACO). 
PLoS Comput Biol. 2012;8(7):e1002549.
 25. Dawson AJ, Yentis SM. Contesting the science/ethics distinction in the 
review of clinical research. J Med Ethics. 2007;33(3):165–7.
 26. Angell EL, Bryman A, Ashcroft RE, Dixon-Woods M. An analysis of deci-
sion letters by research ethics committees: the ethics/scientific quality 
boundary examined. BMJ Qual Saf. 2008;17(2):131–6.
 27. Nichols AS. Research ethics committees (RECS)/institutional review 
boards (IRBS) and the globalization of clinical research: Can ethical 
oversight of human subjects research be standardized. Wash U Global 
Stud L Rev. 2016;15:351.
 28. Garrard E, Dawson A. What is the role of the research ethics committee? 
Paternalism, inducements, and harm in research ethics. J Med Ethics. 
2005;31(7):419–23.
 29. Page SA, Nyeboer J. Improving the process of research ethics review. 
Research Integrity and Peer Review. 2017;2(1):14.
 30. Bowen AJ. Models of institutional review board function. 2008.
 31. McGuinness S. Research ethics committees: the role of ethics in a 
regulatory authority. J Med Ethics. 2008;34(9):695–700.
 32. Kane C, Takechi K, Chuma M, Nokihara H, Takagai T, Yanagawa H. 
Perspectives of non-specialists on the potential to serve as ethics com-
mittee members. J Int Med Res. 2019;47(5):1868–76.
 33. Kirkbride J, George A. Lay REC members: patient and public. J Med Eth-
ics. 2020;39(12):780–2.
 34. Resnik DB. Trust as a Foundation for Research with Human Subjects. The 
Ethics of Research with Human Subjects: Protecting People, Advanc-
ing Science, Promoting Trust. Cham: Springer International Publishing; 
2018. p. 87–111.
 35. Kritikos M. Research Ethics Governance: The European Situation. Hand-
book of Research Ethics and Scientific Integrity. 2020:33–50.
 36. Molina JL, Borgatti SP. Moral bureaucracies and social network research. 
Social Networks [Internet]. 2019;16(11):2020.
 37. Sheehan M, Dunn M, Sahan K. Reasonable disagreement and the justifi-
cation of pre-emptive ethics governance in social research: a response 
to Hammersley. J Med Ethics. 2018;44:719–20.
 38. Mustajoki H. Pre-emptive research ethics: Finnish NationalBoard on 
Research Integrity Tenk; 2018 [Available from: https:// vastu ullin entie de. 
fi/ en/ doing- resea rch/ pre- empti ve- resea rch- ethics.
 39. Biagetti M, Gedutis A. Towards Ethical Principles of Research Evalua-
tion in SSH. The Third Research Evaluation in SSH Conference, Valencia, 
19–20 September 20192019. p. 19–20.
 40. Dove ES. Regulatory Stewardship of Health Research: Edward Elgar 
Publishing; 2020.
 41. Tene O, Polonetsky J. Beyond IRBs: Ethical guidelines for data research. 
Washington and Lee Law Review Online. 2016;72(3):458.
 42. Bloss C, Nebeker C, Bietz M, Bae D, Bigby B, Devereaux M, et al. Reim-
agining human research protections for 21st century science. J Med 
Internet Res. 2016;18(12):e329.
 43. Dove ES, Garattini C. Expert perspectives on ethics review of interna-
tional data-intensive research: Working towards mutual recognition. 
Research Ethics. 2018;14(1):1–25.
 44. van den Broek T, van Veenstra AF. Governance of big data collabora-
tions: How to balance regulatory compliance and disruptive innova-
tion. Technol Forecast Soc Chang. 2018;129:330–8.
 45. Jackman M, Kanerva L. Evolving the IRB: building robust review 
for industry research. Washington and Lee Law Review Online. 
2016;72(3):442.
 46. Someh I, Davern M, Breidbach CF, Shanks G. Ethical issues in big 
data analytics: A stakeholder perspective. Commun Assoc Inf Syst. 
2019;44(1):34.
 47. Friesen P, Redman B, Caplan A. Of Straws, Camels, Research 
Regulation, and IRBs. Therapeutic innovation & regulatory science. 
2019;53(4):526–34.
 48. Kohn T, Shore C. The ethics of university ethics committees. Risk 
management and the research imagination, in Death of the public 
university. 2017:229–49.
 49. Friesen P, Yusof ANM, Sheehan M. Should the Decisions of Insti-
tutional Review Boards Be Consistent? Ethics & human research. 
2019;41(4):2–14.
 50. Binik A, Hey SP. A framework for assessing scientific merit in ethical 
review of clinical research. Ethics & human research. 2019;41(2):2–13.
 51. Derrick GE, Haynes A, Chapman S, Hall WD. The association between 
four citation metrics and peer rankings of research influence of 
Australian researchers in six fields of public health. PLoS ONE. 
2011;6(4):e18521.
Page 12 of 13Ferretti et al. BMC Med Ethics           (2021) 22:51 
 52. Luukkonen T. Conservatism and risk-taking in peer review: Emerging 
ERC practices. Research Evaluation. 2012;21(1):48–60.
 53. Dove ES, Townend D, Meslin EM, Bobrow M, Littler K, Nicol D, et al. 
Ethics review for international data-intensive research. Science. 
2016;351(6280):1399–400.
 54. Abbott L, Grady C. A systematic review of the empirical literature evalu-
ating IRBs: What we know and what we still need to learn. J Empir Res 
Hum Res Ethics. 2011;6(1):3–19.
 55. Shaw DM, Elger BS. The relevance of relevance in research. Swiss Medi-
cal Weekly. 2013;143(1920).
 56. Kosinski Y, Wang M. Deep neural networks are more accurate than 
humans at detecting sexual orientation from facial images. J Pers Soc 
Psychol. 2018;114(2):246–57.
 57. Levin S. LGBT groups denounce ’dangerous’ AI that uses your face to 
guess sexuality: The Guardian; 2017 [updated 2017–09–09. Available 
from: http:// www. thegu ardian. com/ world/ 2017/ sep/ 08/ ai- gay- gaydar- 
algor ithm- facial- recog nition- criti cism- stanf ord.
 58. Tan S, Zhao Y, Huang W. Neighborhood Social Disadvantage and Bicy-
cling Behavior: A Big Data-Spatial Approach Based on Social Indicators. 
Soc Indic Res. 2019;145(3):985–99.
 59. Lynch HF. Opening closed doors: Promoting IRB transparency. J Law 
Med Ethics. 2018;46(1):145–58.
 60. Samuel GN, Farsides B. Public trust and ‘ethics review’as a commodity: 
the case of Genomics England Limited and the UK’s 100,000 genomes 
project. Med Health Care Philos. 2018;21(2):159–68.
 61. Nebeker C, Lagare T, Takemoto M, Lewars B, Crist K, Bloss CS, et al. 
Engaging research participants to inform the ethical conduct of mobile 
imaging, pervasive sensing, and location tracking research. Transla-
tional behavioral medicine. 2016;6(4):577–86.
 62. Clapp JT, Gleason KA, Joffe S. Justification and authority in institutional 
review board decision letters. Soc Sci Med. 2017;194:25–33.
 63. Sheehan M, Friesen P, Balmer A, Cheeks C, Davidson S, Devereux J, et al. 
Trust, trustworthiness and sharing patient data for research. Journal of 
Medical Ethics [Internet]. 2020.
 64. Klitzman R. The ethics police?: The struggle to make human research 
safe: Oxford University Press; 2015.
 65. Cantonal Ethics Committee Zurich. Annual Report 2019. 2019 [Available 
from: https:// www. zh. ch/ conte nt/ dam/ zhweb/ bilder- dokum ente/ 
organ isati on/ gesun dheit sdire ktion/ ethik kommi ssion-/ jahre sberi chte- 
kek/ Jahre sberi cht_ KEK% 20ZH% 202019_ 09- 03- 2020_ PKL. pdf.
 66. Lynch HF, Abdirisak M, Bogia M, Clapp J. Evaluating the quality of 
research ethics review and oversight: a systematic analysis of quality 
assessment instruments. AJOB Empirical Bioethics. 2020:1–15.
 67. Hoffman S. What genetic testing teaches about long-term predictive 
health analytics regulation. 2019.
 68. Obermeyer Z, Powers B, Vogeli C, Mullainathan S. Dissecting racial bias 
in an algorithm used to manage the health of populations. Science. 
2019;366(6464):447–53.
 69. Yoshiura H. Re-identifying people from anonymous histories of their 
activities. 2019 IEEE 10th International Conference on Awareness Sci-
ence and Technology (iCAST); 23–25 Oct. 20192019. p. 1–5.
 70. Holm S, Ploug T. Big Data and Health Research—The Governance 
Challenges in a Mixed Data Economy. Journal of Bioethical Inquiry. 
2017;14(4):515–25.
 71. Nebeker C. mHealth Research Applied to Regulated and Unregulated 
Behavioral Health Sciences. The Journal of Law, Medicine & Ethics. 
2020;48(1_suppl):49–59.
 72. Marks M. Emergent Medical Data: Health Information Inferred by Artifi-
cial Intelligence. UC Irvine Law Review (2021, Forthcoming). 2020.
 73. Friesen P, Douglas Jones R, Marks M, Pierce R, Fletcher K, Mishra A, et al. 
Governing AI-driven health research: are IRBs up to the task? Ethics & 
Human Research. 2020 Forthcoming
 74. Baron J. Life Insurers Can Use Social Media Posts To Determine Premi-
ums, As Long As They Don’t Discriminate: Forbes; 2019 [Available from: 
https:// www. forbes. com/ sites/ jessi cabar on/ 2019/ 02/ 04/ life- insur ers- 
can- use- social- media- posts- to- deter mine- premi ums/.
 75. Wiggins A, Wilbanks J. The rise of citizen science in health and biomedi-
cal research. Am J Bioeth. 2019;19(8):3–14.
 76. Ienca M, Vayena E. “Hunting Down My Son’s Killer”: New Roles of 
Patients in Treatment Discovery and Ethical Uncertainty. Journal of 
Bioethical Inquiry. 2020:1–11.
 77. Grant AD, Wolf GI, Nebeker C. Approaches to governance of participant-
led research: a qualitative case study. BMJ Open. 2019;9(4):e025633.
 78. Mascalzoni D, Hicks A, Pramstaller P, Wjst M. Informed consent in the 
genomics era. PLoS Med. 2008;5(9):e192.
 79. McGuire AL, Beskow LM. Informed consent in genomics and genetic 
research. Annu Rev Genomics Hum Genet. 2010;11:361–81.
 80. Roth S, Luczak-Roesch M. Deconstructing the data life-cycle in digital 
humanitarianism. Inf Commun Soc. 2020;23(4):555–71.
 81. Gal A, Senderovich A. Process Minding: Closing the Big Data Gap. Inter-
national Conference on Business Process Management: Springer; 2020. 
p. 3–16.
 82. Ferretti A, Ienca M, Hurst S, Vayena E. Big Data, Biomedical Research, 
and Ethics Review: New Challenges for IRBs. Ethics & human research. 
2020;42(5):17–28.
 83. Ienca M, Vayena E. Dual use in the 21st century: emerging risks and 
global governance. Swiss Med Wkly. 2018;148:w14688.
 84. Shabani M, Borry P. Rules for processing genetic data for research pur-
poses in view of the new EU General Data Protection Regulation. Eur J 
Hum Genet. 2018;26(2):149–56.
 85. Nebeker C, Harlow J, Espinoza Giacinto R, Orozco-Linares R, Bloss CS, 
Weibel N. Ethical and regulatory challenges of research using pervasive 
sensing and other emerging technologies: IRB perspectives. AJOB 
empirical bioethics. 2017;8(4):266–76.
 86. Sellers C, Samuel G, Derrick G. Reasoning, “uncharted territory”: notions 
of expertise within ethics review panels assessing research use of social 
media. J Empir Res Hum Res Ethics. 2020;15(1–2):28–39.
 87. Schrag ZM. The case against ethics review in the social sciences. 
Research Ethics. 2011;7(4):120–31.
 88. Beskow LM, Hammack-Aviran CM, Brelsford KM, O’Rourke PP. Expert 
Perspectives on Oversight for Unregulated mHealth Research: Empiri-
cal Data and Commentary. The Journal of Law, Medicine & Ethics. 
2020;48(1_suppl):138–46.
 89. Huh-Yoo J, Rader E. It’s the Wild, Wild West: Lessons Learned From IRB 
Members’ Risk Perceptions Toward Digital Research Data. Proceedings 
of the ACM on Human-Computer Interaction. 2020;4(CSCW1):1–22.
 90. Research; NHA. Gene Therapy Advisory Committee 2020 [Available 
from: https:// www. hra. nhs. uk/ about- us/ commi ttees- and- servi ces/ res- 
and- recs/ gene- thera py- advis ory- commi ttee/.
 91. Research; NHA. The Social Care Research Ethics Committee (REC) 2020 
[Available from: https:// www. hra. nhs. uk/ plann ing- and- impro ving- resea 
rch/ polic ies- stand ards- legis lation/ social- care- resea rch/.
 92. Sheehan M, Dunn M, Sahan K. In defence of governance: ethics review 
and social research. J Med Ethics. 2017;44(10):710–6.
 93. NHS UK. When your choice does not apply. 2019 [Avail-
able from: https:// www. nhs. uk/ your- nhs- data- matte rs/ 
where- your- choice- does- not- apply/.
 94. Master Z, Martinson BC, Resnik DB. Expanding the scope of research 
ethics consultation services in safeguarding research integrity: 
Moving beyond the ethics of human subjects research. Am J Bioeth. 
2018;18(1):55–7.
 95. Reisman D, Schultz J, Crawford K. Whittaker M. Algorithmic impact 
assessments: A practical framework for public agency accountability. AI 
Now Institute; 2018. p. 1–22.
 96. Sheehan M. Broad consent is informed consent Bmj. 2011;343:d6900.
 97. Sheehan M, Thompson R, Fistein J, Davies J, Dunn M, Parker M, et al. 
Authority and the Future of Consent in Population-Level Biomedical 
Research. Public Health Ethics. 2019;12(3):225–36.
 98. Montréal; Ud. Montréal Declaration for a Responsible Development of 
Artificial Intelligence 2019 [Available from: https:// www. montr ealde 
clara tion- respo nsibl eai. com.
 99. McCoy MS, Jongsma KR, Friesen P, Dunn M, Neuhaus CP, Rand L, et al. 
National Standards for Public Involvement in Research: missing the 
forest for the trees. J Med Ethics. 2018;44(12):801–4.
 100. Brown C, Spiro J, Quinton S. The role of research ethics committees: 
Friend or foe in educational research? An exploratory study. Br Edu Res 
J. 2020;46(4):747–69.
 101. Pagoto S, Nebeker C. How scientists can take the lead in establishing 
ethical practices for social media research. J Am Med Inform Assoc. 
2019;26(4):311–3.
Page 13 of 13Ferretti et al. BMC Med Ethics           (2021) 22:51  
•
 
fast, convenient online submission
 •
  
thorough peer review by experienced researchers in your field
• 
 
rapid publication on acceptance
• 
 
support for research data, including large and complex data types
•
  
gold Open Access which fosters wider collaboration and increased citations 
 
maximum visibility for your research: over 100M website views per year •
  At BMC, research is always in progress.
Learn more biomedcentral.com/submissions
Ready to submit your research ?  Choose BMC and benefit from: 
 102. Harlow J, Weibel N, Al Kotob R, Chan V, Bloss C, Linares-Orozco R, 
et al. Using participatory design to inform the Connected and Open 
Research Ethics (CORE) commons. Sci Eng Ethics. 2020;26(1):183–203.
 103. Vayena E, Blasimme A. Health research with big data: Time for systemic 
oversight. J Law Med Ethics. 2018;46(1):119–29.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in pub-
lished maps and institutional affiliations.
